{
   "journal":"BMJ",
   "pubID":"abrd041828",
   "file":"bmj.k872",
   "section":"Research",
   "series":"",
   "title":"Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study",
   "firstAuthor":"Devin Abrahami",
   "graphics":"abrd041828.f1,abrd041828.f2",
   "dataSupplements":"abrd041828.ww1",
   "username":"la_bmjprod",
   "report":"../qa_reports/abrd041828-QA-report.html","status":"Sent to HWX",
   "info":"",
   "pubHWX":"ppr",
   "embargoDate":"2018/3/21",
   "embargoTime":"",
   "vol":"360",
   "articleLink":"http://dx.doi.org/10.1136/bmj.k872","hwBatch":"bmj_arts_360_mar21_6"
}